Biomimetic Innovations Team meets with Sanara Medtech in Dallas Texas

The Biomimetic Innovations team were thrilled to join Sanara Medtech in Dallas, TX last week for their first dedicated training session on OsStic®.
In January this year BMI entered into an exclusive U.S. license and distribution agreement (Trauma) and made a minority investment in Sanara MedTech (Nasdaq: SMTI).
This training event represents a key milestone on the path to bringing OsStic® into clinical use for patients across the U.S.
We’re excited to collaborate with Sanara MedTech in pursuit of our shared mission: to enhance patient wellbeing.

#OsStic #bioadhesive #acceleratingmedicalinnovation #pbcbiomed #sanaramedtech #partnership